1 Introduction to Research & Analysis Reports
1.1 Antipyretic Analgesic Anti-Inflammatory Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antipyretic Analgesic Anti-Inflammatory Drugs Overall Market Size
2.1 Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Size: 2022 VS 2029
2.2 Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Antipyretic Analgesic Anti-Inflammatory Drugs Players in Global Market
3.2 Top Global Antipyretic Analgesic Anti-Inflammatory Drugs Companies Ranked by Revenue
3.3 Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue by Companies
3.4 Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales by Companies
3.5 Global Antipyretic Analgesic Anti-Inflammatory Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antipyretic Analgesic Anti-Inflammatory Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antipyretic Analgesic Anti-Inflammatory Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antipyretic Analgesic Anti-Inflammatory Drugs Players in Global Market
3.8.1 List of Global Tier 1 Antipyretic Analgesic Anti-Inflammatory Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Antipyretic Analgesic Anti-Inflammatory Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Size Markets, 2022 & 2029
4.1.2 Paracetamol
4.1.3 Aspirin
4.1.4 Ibuprofen
4.1.5 Naproxen
4.1.6 Diclofenac
4.1.7 Oxaprozin
4.1.8 Dexibuprofen
4.1.9 Others
4.2 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue & Forecasts
4.2.1 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2023
4.2.2 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2024-2029
4.2.3 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales & Forecasts
4.3.1 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2023
4.3.2 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2024-2029
4.3.3 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Antipyretic Analgesic Anti-Inflammatory Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue & Forecasts
5.2.1 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2023
5.2.2 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2024-2029
5.2.3 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales & Forecasts
5.3.1 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2023
5.3.2 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2024-2029
5.3.3 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Antipyretic Analgesic Anti-Inflammatory Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2022 & 2029
6.2 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue & Forecasts
6.2.1 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2023
6.2.2 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2024-2029
6.2.3 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales & Forecasts
6.3.1 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2023
6.3.2 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2024-2029
6.3.3 By Region – Global Antipyretic Analgesic Anti-Inflammatory Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2029
6.4.2 By Country – North America Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2029
6.4.3 US Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.4.4 Canada Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.4.5 Mexico Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2029
6.5.3 Germany Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.4 France Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.5 U.K. Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.6 Italy Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.7 Russia Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.5.9 Benelux Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2029
6.6.3 China Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.6.4 Japan Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.6.5 South Korea Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.6.7 India Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2029
6.7.2 By Country – South America Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2029
6.7.3 Brazil Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.7.4 Argentina Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antipyretic Analgesic Anti-Inflammatory Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antipyretic Analgesic Anti-Inflammatory Drugs Sales, 2018-2029
6.8.3 Turkey Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.8.4 Israel Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
6.8.6 UAE Antipyretic Analgesic Anti-Inflammatory Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Company Summary
7.1.2 Mallinckrodt Pharmaceuticals Business Overview
7.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.2 IOL
7.2.1 IOL Company Summary
7.2.2 IOL Business Overview
7.2.3 IOL Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.2.4 IOL Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.2.5 IOL Key News & Latest Developments
7.3 Anqiu Lu’an Pharmaceutical
7.3.1 Anqiu Lu’an Pharmaceutical Company Summary
7.3.2 Anqiu Lu’an Pharmaceutical Business Overview
7.3.3 Anqiu Lu’an Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.3.4 Anqiu Lu’an Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Anqiu Lu’an Pharmaceutical Key News & Latest Developments
7.4 Novacyl
7.4.1 Novacyl Company Summary
7.4.2 Novacyl Business Overview
7.4.3 Novacyl Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.4.4 Novacyl Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novacyl Key News & Latest Developments
7.5 BASF
7.5.1 BASF Company Summary
7.5.2 BASF Business Overview
7.5.3 BASF Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.5.4 BASF Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.5.5 BASF Key News & Latest Developments
7.6 Anhui BBCA Pharmaceuticals
7.6.1 Anhui BBCA Pharmaceuticals Company Summary
7.6.2 Anhui BBCA Pharmaceuticals Business Overview
7.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Anhui BBCA Pharmaceuticals Key News & Latest Developments
7.7 Hubei Biocause
7.7.1 Hubei Biocause Company Summary
7.7.2 Hubei Biocause Business Overview
7.7.3 Hubei Biocause Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.7.4 Hubei Biocause Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hubei Biocause Key News & Latest Developments
7.8 Xinhua Pharm
7.8.1 Xinhua Pharm Company Summary
7.8.2 Xinhua Pharm Business Overview
7.8.3 Xinhua Pharm Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.8.4 Xinhua Pharm Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Xinhua Pharm Key News & Latest Developments
7.9 Granules India Limited
7.9.1 Granules India Limited Company Summary
7.9.2 Granules India Limited Business Overview
7.9.3 Granules India Limited Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.9.4 Granules India Limited Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Granules India Limited Key News & Latest Developments
7.10 Huagang Pharm
7.10.1 Huagang Pharm Company Summary
7.10.2 Huagang Pharm Business Overview
7.10.3 Huagang Pharm Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.10.4 Huagang Pharm Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Huagang Pharm Key News & Latest Developments
7.11 Hebei Jiheng Pharmaceutical
7.11.1 Hebei Jiheng Pharmaceutical Company Summary
7.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Business Overview
7.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Hebei Jiheng Pharmaceutical Key News & Latest Developments
7.12 Zhejiang Kangle Pharmaceutical
7.12.1 Zhejiang Kangle Pharmaceutical Company Summary
7.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Business Overview
7.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Zhejiang Kangle Pharmaceutical Key News & Latest Developments
7.13 Hebei Jingye Medical Technology
7.13.1 Hebei Jingye Medical Technology Company Summary
7.13.2 Hebei Jingye Medical Technology Antipyretic Analgesic Anti-Inflammatory Drugs Business Overview
7.13.3 Hebei Jingye Medical Technology Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.13.4 Hebei Jingye Medical Technology Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Hebei Jingye Medical Technology Key News & Latest Developments
7.14 MSPF
7.14.1 MSPF Company Summary
7.14.2 MSPF Business Overview
7.14.3 MSPF Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.14.4 MSPF Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.14.5 MSPF Key News & Latest Developments
7.15 Lu’an Pharmaceutical
7.15.1 Lu’an Pharmaceutical Company Summary
7.15.2 Lu’an Pharmaceutical Business Overview
7.15.3 Lu’an Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.15.4 Lu’an Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Lu’an Pharmaceutical Key News & Latest Developments
7.16 Mallinckrodt
7.16.1 Mallinckrodt Company Summary
7.16.2 Mallinckrodt Business Overview
7.16.3 Mallinckrodt Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.16.4 Mallinckrodt Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Mallinckrodt Key News & Latest Developments
7.17 Farmson
7.17.1 Farmson Company Summary
7.17.2 Farmson Business Overview
7.17.3 Farmson Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.17.4 Farmson Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Farmson Key News & Latest Developments
7.18 Anhui Fubore
7.18.1 Anhui Fubore Company Summary
7.18.2 Anhui Fubore Business Overview
7.18.3 Anhui Fubore Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.18.4 Anhui Fubore Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Anhui Fubore Key News & Latest Developments
7.19 SKPL
7.19.1 SKPL Company Summary
7.19.2 SKPL Business Overview
7.19.3 SKPL Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.19.4 SKPL Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.19.5 SKPL Key News & Latest Developments
7.20 Atabay
7.20.1 Atabay Company Summary
7.20.2 Atabay Business Overview
7.20.3 Atabay Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.20.4 Atabay Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Atabay Key News & Latest Developments
7.21 Huzhou Konch Pharmaceutical
7.21.1 Huzhou Konch Pharmaceutical Company Summary
7.21.2 Huzhou Konch Pharmaceutical Business Overview
7.21.3 Huzhou Konch Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.21.4 Huzhou Konch Pharmaceutical Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Huzhou Konch Pharmaceutical Key News & Latest Developments
7.22 Anhui Topsun
7.22.1 Anhui Topsun Company Summary
7.22.2 Anhui Topsun Business Overview
7.22.3 Anhui Topsun Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.22.4 Anhui Topsun Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Anhui Topsun Key News & Latest Developments
7.23 SOLARA
7.23.1 SOLARA Company Summary
7.23.2 SOLARA Business Overview
7.23.3 SOLARA Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.23.4 SOLARA Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.23.5 SOLARA Key News & Latest Developments
7.24 SI Group
7.24.1 SI Group Company Summary
7.24.2 SI Group Business Overview
7.24.3 SI Group Antipyretic Analgesic Anti-Inflammatory Drugs Major Product Offerings
7.24.4 SI Group Antipyretic Analgesic Anti-Inflammatory Drugs Sales and Revenue in Global (2018-2023)
7.24.5 SI Group Key News & Latest Developments
8 Global Antipyretic Analgesic Anti-Inflammatory Drugs Production Capacity, Analysis
8.1 Global Antipyretic Analgesic Anti-Inflammatory Drugs Production Capacity, 2018-2029
8.2 Antipyretic Analgesic Anti-Inflammatory Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Antipyretic Analgesic Anti-Inflammatory Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antipyretic Analgesic Anti-Inflammatory Drugs Supply Chain Analysis
10.1 Antipyretic Analgesic Anti-Inflammatory Drugs Industry Value Chain
10.2 Antipyretic Analgesic Anti-Inflammatory Drugs Upstream Market
10.3 Antipyretic Analgesic Anti-Inflammatory Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antipyretic Analgesic Anti-Inflammatory Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の解熱鎮痛抗炎症薬市場予測2023-2029：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他 |
| 【英語タイトル】Antipyretic Analgesic Anti-Inflammatory Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5690 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：121 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の解熱鎮痛抗炎症薬市場規模と予測を収録しています。・世界の解熱鎮痛抗炎症薬市場：売上、2018年-2023年、2024年-2029年 ・世界の解熱鎮痛抗炎症薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の解熱鎮痛抗炎症薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「パラセタモール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 解熱鎮痛抗炎症薬のグローバル主要企業は、Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、解熱鎮痛抗炎症薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の解熱鎮痛抗炎症薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の解熱鎮痛抗炎症薬市場：タイプ別市場シェア、2022年 ・パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他 世界の解熱鎮痛抗炎症薬市場：用途別、2018年-2023年、2024年-2029年 世界の解熱鎮痛抗炎症薬市場：用途別市場シェア、2022年 ・大人、子供 世界の解熱鎮痛抗炎症薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の解熱鎮痛抗炎症薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における解熱鎮痛抗炎症薬のグローバル売上、2018年-2023年 ・主要企業における解熱鎮痛抗炎症薬のグローバル売上シェア、2022年 ・主要企業における解熱鎮痛抗炎症薬のグローバル販売量、2018年-2023年 ・主要企業における解熱鎮痛抗炎症薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Group ************************************************************* ・調査・分析レポートの概要 解熱鎮痛抗炎症薬市場の定義 市場セグメント 世界の解熱鎮痛抗炎症薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の解熱鎮痛抗炎症薬市場規模 世界の解熱鎮痛抗炎症薬市場規模：2022年 VS 2029年 世界の解熱鎮痛抗炎症薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの解熱鎮痛抗炎症薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の解熱鎮痛抗炎症薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他 解熱鎮痛抗炎症薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：大人、子供 解熱鎮痛抗炎症薬の用途別グローバル売上・予測 ・地域別市場分析 地域別解熱鎮痛抗炎症薬市場規模 2022年と2029年 地域別解熱鎮痛抗炎症薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Group ... |
Antipyretic Analgesic Agent are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesic Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesic Anti-Inflammatory Drugs. This report contains market size and forecasts of Antipyretic Analgesic Anti-Inflammatory Drugs in global, including the following market information:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Antipyretic Analgesic Anti-Inflammatory Drugs companies in 2022 (%)
The global Antipyretic Analgesic Anti-Inflammatory Drugs market was valued at US$ 2789.5 million in 2022 and is projected to reach US$ 3123.1 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antipyretic Analgesic Anti-Inflammatory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Type, 2022 (%)
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Antipyretic Analgesic Anti-Inflammatory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs revenues share in global market, 2022 (%)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Antipyretic Analgesic Anti-Inflammatory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu’an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipyretic Analgesic Anti-Inflammatory Drugs, market overview.
Chapter 2: Global Antipyretic Analgesic Anti-Inflammatory Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Antipyretic Analgesic Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipyretic Analgesic Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antipyretic Analgesic Anti-Inflammatory Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の解熱鎮痛抗炎症薬市場予測2023-2029：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他] (コード：MMG23JU5690)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の解熱鎮痛抗炎症薬市場予測2023-2029：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他]についてメールでお問い合わせ |
